首页> The New England journal of medicine> An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.

An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Robert,Bissonnette

第一单位： From Innovaderm Research, Montreal (R.B.), McMaster University and Dermatrials Research, Hamilton, ON (R.V.), Alliance Clinical Trials and Probity Medical Research, Waterloo, ON (K.P.), and the Division of Dermatology, Department of Medicine, University of Toronto, Toronto (K.P.) - all in Canada; Goethe University Frankfurt, Frankfurt am Main (A.P.), and the Center for Inflammatory Skin Diseases, University Medical Center Schleswig-Holstein Campus Kiel, Kiel (S.G.) - both in Germany; the University of Pittsburgh, Pittsburgh (L.K.F.), and Janssen Research and Development, Spring House (M.M., Y.-K.S., A.K., S.L., C.D.) - both in Pennsylvania; and Oregon Dermatology and Research Center, Portland (P.R.).

作者： Robert,Bissonnette ^[1] ; Andreas,Pinter ^[1] ; Laura K,Ferris ^[1] ; Sascha,Gerdes ^[1] ; Phoebe,Rich ^[1] ; Ronald,Vender ^[1] ; Megan,Miller ^[1] ; Yaung-Kaung,Shen ^[1] ; Arun,Kannan ^[1] ; Shu,Li ^[1] ; Cynthia,DeKlotz ^[1] ; Kim,Papp ^[1]

作者单位： From Innovaderm Research, Montreal (R.B.), McMaster University and Dermatrials Research, Hamilton, ON (R.V.), Alliance Clinical Trials and Probity Medical Research, Waterloo, ON (K.P.), and the Division of Dermatology, Department of Medicine, University of Toronto, Toronto (K.P.) - all in Canada; Goethe University Frankfurt, Frankfurt am Main (A.P.), and the Center for Inflammatory Skin Diseases, University Medical Center Schleswig-Holstein Campus Kiel, Kiel (S.G.) - both in Germany; the University of Pittsburgh, Pittsburgh (L.K.F.), and Janssen Research and Development, Spring House (M.M., Y.-K.S., A.K., S.L., C.D.) - both in Pennsylvania; and Oregon Dermatology and Research Center, Portland (P.R.). ^[1]